How long do children need to remain on anti-clotting medications for the treatment of a blood clot?

For many children who have developed DVT/PE with contributing factors identified (in other words, whose DVT/PE did not occur “out of the blue”), the length of treatment with anti-clotting medications can be as short as six weeks, especially if the contributing factors are no longer present, or much less significant, by that time. This was shown in a recent multi-national research study called Kids-DOTT, funded by the U.S. National Institutes of Health.

However, for children whose DVT/PE have no contributing factors identified, or who have had another DVT/PE in the past, or who for other reasons do not fit the features of children who participated in Kids-DOTT, the length of treatment with anti-clotting medications is typically three months.

For children whose DVT/PE had no contributing factors identified, or who have strong and long-lasting risk factors for developing new DVT/PE, or who have had multiple prior DVTs/PEs, the length of treatment may be six to 12 months or even life-long.

Neil A. Goldenberg, MD, PhD

Professor of Pediatrics and Medicine, Johns Hopkins University School of Medicine,
Baltimore, MD, USA

Founding Director, Pediatric Thrombosis & Stroke Programs
Johns Hopkins All Children’s Hospital
St. Petersburg, FL, USA

Updated: September 2024

Download: Blood Clots and Children Resource PDF

Blood Clots in Children

Current News

March Recognized as Blood Clot Awareness Month Across the U.S.

Throughout March, states and cities across the country have officially recognized Blood Clot Awareness Month, reinforcing the importance of education…

March is Blood Clot Awareness Month

March is Blood Clot Awareness Month (BCAM), a time dedicated to spreading the word about blood clots and their potentially…